Cygnus' transdermal nicotine patch
Executive Summary
FDA review is "in the final stages and a preapproval inspection has been scheduled," Associate Director of Biophysical Research Russell Potts, PhD, tells the Mabon Securities Drug Delivery Research Conference on Feb. 19 in New York City. Three other nicotine patch products have already been approved -- Marion Merrell Dow/Alza's Nicoderm, Ciba-Geigy's Habitrol and Elan/Lederle's ProStep.
FDA review is "in the final stages and a preapproval inspection has
been scheduled," Associate Director of Biophysical Research Russell
Potts, PhD, tells the Mabon Securities Drug Delivery Research
Conference on Feb. 19 in New York City. Three other nicotine patch
products have already been approved -- Marion Merrell Dow/Alza's
Nicoderm, Ciba-Geigy's Habitrol and Elan/Lederle's ProStep. |